Status:
ACTIVE_NOT_RECRUITING
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
Lead Sponsor:
Shandong Provincial Hospital
Conditions:
Early Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
HCC is one of most common causes of cancer-related death in the world due to lately diagnosis by typical hallmarks which rely on completed arterialization. So it is important to earlier diagnose and t...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Patients with chronic liver disease who are at high/extremely high-risk of hepatocellular carcinoma;
- EOB-MRI suggestive of confirmed or suspected eHCC (single lesion ≤ 2 cm or number of lesions ≤ 3 and maximum diameter ≤ 2 cm)
- No previous history of hepatocellular carcinoma;
- Not receiving any anti-cancer treatment;
- Liver function Child-push A or B.
Exclusion
- Presence of lymph nodes or distant metastases;
- Presence of liver metastases;
- Prior malignancy;
- Severe cardiopulmonary or renal dysfunction;
- Suffering from uncorrectable coagulation dysfunction (prothrombin time \> 25 seconds, prothrombin activity \< 40%, platelet count ≤ 50x10\^9/L);
- Severe infectious lesions in the area of the puncture needle tract.
Key Trial Info
Start Date :
August 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2030
Estimated Enrollment :
334 Patients enrolled
Trial Details
Trial ID
NCT06096896
Start Date
August 30 2023
End Date
September 30 2030
Last Update
October 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shandong PH
Jinan, China